| Literature DB >> 32962482 |
Yaodong Wang1, Chi Yao1, Zhuo Yang2, Wenlai Guo3.
Abstract
OBJECTIVE: The clinical efficacy of platelet-rich plasma (PRP) as adjuvant therapy in patients undergoing arthroscopic repair of meniscal injury remains controversial. This meta-analysis was performed to evaluate the clinical efficacy of PRP in the treatment of meniscal injury and provide evidence for the selection of clinical treatment options.Entities:
Keywords: Platelet-rich plasma; active flexion; adjuvant therapy; arthroscopic meniscal repair; failure rate; meniscal injury; meta-analysis; pain
Mesh:
Year: 2020 PMID: 32962482 PMCID: PMC7520921 DOI: 10.1177/0300060520955059
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Flowchart of study selection in the present meta-analysis.
Main characteristics of all eligible studies included in the meta-analysis.
| Authors, year [Ref] | Research type | Patients (n) | Mean age (years) | Follow-up (months) | Jadad/NOS | |||
|---|---|---|---|---|---|---|---|---|
| Surg | NS | Surg | NS | Surg | NS | |||
| Pujol et al., 2014 [11] | Cohort | 17 | 17 | 28.3 | 32.3 | 30 | 34 | 5 |
| Duif et al., 2015 [12] | RCT | 15 | 20 | 64.1 | 64.3 | 12 | 12 | 5 |
| Griffin et al., 2015 [13] | Cohort | 53 | 44 | 26 | 35 | 48 | 48 | 6 |
| Kaminski et al., 2018 [14] | RCT | 21 | 18 | 30 | 26 | 54 | 54 | 7 |
| Dai et al., 2019 [15] | Cohort | 14 | 15 | 32.4 | 30.3 | 20.6 | 20.6 | 6 |
| Kaminski et al., 2019 [16] | RCT | 37 | 22 | 44 | 46 | 23 | 23 | 7 |
RCT, randomized controlled trial; Surg, surgical intervention; NS, nonsurgical intervention; NOS, Newcastle–Ottawa Scale.
Selection of surgical outcomes.
| Authors, year [Ref] | IKDC score | Lysholm score | VAS score | Active flexion | Failure rate | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Surg | NS | Surg | NS | Surg | NS | Surg | NS | Surg | NS | |
| Pujol et al. 2014 [11] | 90.7 ± 13 | 87.9 ± 25.25 | 135 ± 6.25 | 130 ± 6.25 | 1/17 | 2/17 | ||||
| Duif et al., 2015 [12] | 83.2 ± 18 | 70 ± 17.1 | −1.5 ± 2.27 | −0.7 ± 2.11 | ||||||
| Griffin et al., 2015 [13] | 69 ± 26 | 76 ± 17 | 66 ± 31.9 | 89 ± 9.7 | 125 ± 11.25 | 119 ± 10 | 4/15 | 5/29 | ||
| Kaminski et al., 2018 [14] | 97.56 ± 0.63 | 84.77 ± 0.92 | −5.37 ± 0.1 | −4.17 ± 0.11 | 3/20 | 9/17 | ||||
| Dai et al., 2019 [15] | 79.8 ± 9.6 | 74.6 ± 11.6 | −2.9 ± 1 | −1.8 ± 1.21 | ||||||
| Kaminski et al., 2019 [16] | 85.98 ± 0.52 | 88.12 ± 0.89 | −3.62 ± 0.07 | −2.36 ± 0.09 | 13/27 | 19/27 | ||||
Data are presented as mean ± standard deviation or number of patients.
IKDC, International Knee Documentation Committee; VAS, visual analog scale; Surg, surgical intervention; NS, nonsurgical intervention.
Figure 2.Forest plot of International Knee Documentation Committee score.
Figure 3.Forest plot of Lysholm score.
Figure 4.Forest plot of visual analog scale score change.
Figure 5.Forest plot of active flexion.
Figure 6.Forest plot of failure rate.